论文部分内容阅读
胃癌是我国常见的恶性肿瘤之一。据统计,我国每年新发胃癌患者达40万人,死亡人数达30万人,均居世界首位。现有研究表明,仅依靠外科治疗难以改善患者的生存率,少数患者最终死于复发转移,胃癌依然是临床肿瘤学界面临的巨大挑战。由于化疗缓解率低而毒性高,同时部分复发或转移患者临床状况不佳,无法承受强烈化疗,因此积极研发高效、
Gastric cancer is one of the common malignant tumors in our country. According to statistics, there are 400,000 new cases of gastric cancer in our country every year, with the death toll reaching 300,000, ranking first in the world. Existing research shows that it is difficult to improve the survival rate of patients only by surgical treatment, a small number of patients eventually died of recurrence and metastasis, gastric cancer remains a huge challenge facing clinical oncology. Due to the low rate of chemotherapy and high toxicity, while some patients with recurrent or metastatic disease in poor clinical conditions, can not afford strong chemotherapy, and therefore actively develop efficient,